In preclinical drug development, in vivo studies are a mandatory step in the process of turning lead compounds into drug candidates. Regulatory agencies require in vivo safety and efficacy data from animal models before approving novel candidates for human clinical trials. While animal studies...Read more
Lab of the Future is now
Drug discovery and development lead to new treatments for diseases. However, it is a costly, time-consuming and challenging process—developing a marketable drug can take more than 10 years and cost around a billion dollars. One of the reasons for this high cost is that nearly 90% of drugs...
In recent years, the reproducibility of scientific research has come under the spotlight. A major barrier to clinical development is the inability of translational scientists to replicate early discovery findings. In 2016, Nature surveyed nearly 1,600 scientists and found that 70 percent of...Read more
Data integrity is not a new problem and continues to be the major focus in regulated cGMP laboratories worldwide due to data falsification, poor data management practices, or ignorance of the regulations. Several regulatory agencies such as the Medicines and Healthcare products Regulatory Agency...Read more
When the human genome was sequenced in 2003, it became possible to identify the gene and protein changes that occur in various diseases, such as cancer. Ever since, the field of proteomics has been booming to respond to the ever-increasing prevalence of chronic diseases. Today, the global market...Read more
Research scientists spend 50-80% of their time at the bench with no easy way to record data or access information. New voice-powered digital tools solve this problem by connecting scientists with information at the point of experimentation.Read more